Jiangsu Kanion Pharmaceutical Co.,Ltd. Financials

Market Capitalization CN¥7.63 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	13.96
Forward PE	12.04
Price to Sales TTM	CN¥1.70
Price to Book MRQ	CN¥1.45
Enterprise to Revenue	1.25
Enterprise to EBITDA	9.82

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	12.15%
Operating Margin	8.50%
Return on Assets TTM	3.55%
Return on Equity TTM	10.48%

Income Statement

Revenue TTM	CN¥4,481,311,744
Revenue per Share TTM	CN¥7.73
Quarterly Revenue Growth	-9.90%
Gross Profit TTM	CN¥3,343,605,504
EBITDA	CN¥516,900,803
Net Income to Common TTM	CN¥544,351,488
Diluted EPS TTM	CN¥0.94
Quarterly Earnings Growth YoY	24.30%

Balance Sheet

Total Cash MRQ	CN¥2,141,857,536
Total Cash per Share MRQ	CN¥3.76
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	0.04
Current Ratio MRQ	2.60
Book Value per Share MRQ	CN¥9.04

Cash Flow

Operating Cash Flow TTM	CN¥874,795,520
Levered Free Cash Flow TTM	CN¥-91,126,096

600557 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	581,796,992
Float Shares	345,826,820
Avg 10 Volume	6,405,600
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	42.82%
% Held by Institutions	11.84%

Stock Price Summary

Beta	0.47
Fifty Two Week Low	CN¥11.77
Fifty Two Week High	CN¥24.09
Fifty Two Week Change	-34.91%
Day 50 MA	CN¥14.10
Day 200 MA	CN¥15.43

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.49
Forward Annual Dividend Yield	11.34%
Trailing Annual Dividend Rate	CN¥0.37
Trailing Annual Dividend Yield	2.84%
Payout Ratio	39.58%
Dividend Date
Ex Dividend Date	2024-05-31
Last Split Factor
Last Split Date	2016-06-24